← SynDRA
MK-571
SynDRA canonical compound SYN0000807 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ABCC2 | CYSLTR1 |
|---|
| Mechanism of action | leukotriene receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- leukotriene receptor antagonist
- CYSLTR1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- SLCO1B1
- ABCC1
- ABCC3
- ABCC4
- SLCO2B1
- ABCB11
- SLCO1B3
- ABCB1
- USP1
- TDP1
- GMNN
- KAT2A
- HDAC6
- ABCG2
- ABCC5
- ABCC11
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- ANDR
- ATAD5
- CYSLTR2
- ESR1
- GCR
- NR1I2
- TP53
- UBP1
Cross-references
Synonyms
- L-660771
- RefChem:198146
- L-660711
- MK-0571
- MK571
- C26H27ClN2O3S2
- UNII-76LB1G2X6V
- L-660,711
- UNII:76LB1G2X6V
- CHEBI:6619
- orb1299457
- orb1706018
- SCHEMBL9231584
- SCHEMBL30509651
- BDBM86671
- GTPL10346
- QEA10428
- BDBM50001285
- CAS_60719
- MFCD00797675
- NSC_60719
- PDSP1_001581
- PDSP2_001565
- AKOS024457058
- AC-35387
- DA-55523
- DA-68482
- HY-19989
- LS-15140
- CS-0017876
- NS00120280
- T7841
- H37003
- T19674
- L002207
- SR-01000946824
- SR-01000946824-1
- BRD-A73679382-236-01-8
- NCGC00163509-01
Look up MK-571 in the interactive SynDRA portal →